ROWLAND THOMAS ANDREW (SVP, HEAD - ESTABLISHED BRANDS) sold 11.0% of their position (4.77K shares) of ANI PHARMACEUTICALS INC on the open market
Open‑market sale worth $357.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/13/2026ACC: 0001507496-26-000009
Officer· SVP, HEAD - ESTABLISHED BRANDS
Since Feb 2026
-4.77K
Net shares
Net seller
$357.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.77K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.77K
Price / share
$74.91
Trade value
$357.47K
% of position
11.0%
3/11/2026
43.50K→38.73K
Total
Net shares
−4.77K
Net value
-$357.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −4.77K | $74.91 | $357.47K | 11.0% | 43.50K | 38.73K |
| Total | −4.77K | -$357.47K | ||||||
Derivative Transactions0
No derivative transactions reported